---

Life expectancy at birth (years), 2021: 74.4
Maternal mortality ratio (per 100,000 live births), 2023: 12
Under-five mortality rate (per 1000 live births), 2023: 3.8
Neonatal mortality rate (per 1000 live births), 2023: 2.1
Tuberculosis incidence (per 100,000 population), 2023: 5.9
Probability of dying from any of CVD, cancer, diabetes, CRD between age 30 and exact age 70 (%), 2021: 21.7%
Suicide mortality rate (per 100,000 population), 2021: 16.5
Adolescent birth rate (per 1000 women aged 15-19 years), 2015-2024: 16.7
Adolescent birth rate (per 1000 women aged 10-14 years), 2015-2024: 0.2
Diphtheria-tetanus-pertussis (DTP3) immunization coverage among 1-year-olds (%), 2023: 99%
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%), 2023: 99%
Pneumococcal conjugate 3rd dose (PCV3) immunization coverage among 1-year olds (%), 2023: 99%
Human papillomavirus (HPV) immunization coverage estimates among 15 year-old girls (%), 2023: 75%
Prevalence of anaemia in women aged 15-49 years (%), 2023: 24.1%

Source: World health statistics 2025: monitoring health for the SDGs, Sustainable Development Goals. Tables of health statistics by country and area, WHO region and globally. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO.

---

Congestive heart failure hospital admission in adults, age-sex standardized rate per 100,000 population, 2011: 501
Asthma and chronic obstructive pulmonary disease hospital admissions in adults, age-sex standardized rate per 100,000 population, 2011: 476

Source: OECD (2023), Health at a Glance 2023: OECD Indicators, OECD Publishing, Paris, doi.org/10.1787/7a7afb35-en.

---

“The rate of preventable deaths in Hungary decreased in the last decade to 315 per 100,000 population in 2019, although it remained one of the highest in the EU over the same period. This spiked to 350 deaths per 100,000 population in 2020, which is partly explained by the fact that deaths attributed to COVID-19 have been classified as preventable in mortality statistics since 2020 (Figure 10). The three leading causes of preventable mortality in Hungary in 2020 were lung cancer (18 %), ischaemic heart disease (15 %) and alcohol-related diseases (11 %). Hungary has the largest prevalence of preventable deaths from lung cancer in the EU.

“As with preventable mortality, deaths from treatable causes are also relatively high in Hungary. Though the rate declined in the last decade to 173 per 100,000 population in 2019, it rose to 180 per 100,000 in 2020. The three leading causes are ischaemic heart disease (29 %), which is one of the highest rates in the EU, colorectal cancer (16 %) and stroke (11 %).”

Source: OECD/European Observatory on Health Systems and Policies (2023), Hungary: Country Health Profile 2023, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels.

---

“In 2019, to improve prevention in Hungary, the Minister of Human Capacities introduced five national health programmes for 2019-22 covering child health, circulatory diseases, mental health, musculoskeletal disorders and cancer. An initiative to develop a new national health programme was announced in 2023, but the new plans are still in their initial stages. Other prominent policies to improve public health and prevention include an expansion of the Public Health Product Tax to items such as alcopops and a planned investment of HUF 83.5 billion (EUR 229 million) for sports facilities.”

Source: OECD/European Observatory on Health Systems and Policies (2023), Hungary: Country Health Profile 2023, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels.

---

“Cancer screening rates for breast and cervical cancer were declining in Hungary before the COVID-19 pandemic. They decreased further due to the implemented lockdown measures to contain the spread of the virus, such as the temporary suspension of all oncological screening activities in mid-March 2020 and again in April 2021. In 2019, 39.1 % of women aged 50-69 years were screened for breast cancer in the previous two years; this rate declined during the pandemic to 33.7 % in 2020 and further to 29.8 % in 2021 (Figure 11). The same trend of gradual decline between 2019 and 2021 emerges when looking at the screening rate for cervical cancer among women aged 20-69. In 2018, a screening programme was introduced for colorectal cancer among those aged 50-70 years. In 2021, the participation rate in the screening programme was 2.8 %, the lowest among the 16 EU countries reporting data on colorectal cancer screenings.

“There are notable differences in screening participation across educational and income levels. For example, 72.5 % of women aged 20-69 yearswith a higher education reported having accessed cervical cancer screening at least once within the past two years. For women aged 20-69 years with a lower education, the self-reported rate was only 45.7 %. For income levels, the same picture emerges, as the difference among women with higher (75.1 %) and lower (50.8 %) incomes is also pronounced.”

Source: OECD/European Observatory on Health Systems and Policies (2023), Hungary: Country Health Profile 2023, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels.

---

---

World Health Systems Facts is a project of the Real Reporting Foundation. We provide reliable statistics and other data from authoritative sources regarding health systems and policies in the US and sixteen other OECD member nations.

Page last updated July 9, 2025 by Doug McVay, Editor.